PSCore platform delivered over 500 characterized iPSC lines during first year of collaboration . SAN DIEGO, CA, 11 March 2026 ...

XCells Biotechnologies USA Inc. has delivered over 500 characterized induced pluripotent stem cell lines as part of a multi-year collaboration with a global biotechnology company.

Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 years), with China commercial launch targeted for 2026 – relevant to ...

REPROCELL (TYO: 4978) today announced the launch of its US FDA compliant Good Manufacturing Practice (GMP) Master Cell Bank (MCB) manufacturing service for human induced pluripotent stem cells (iPSCs) ...

Integrated Workflow Including Clinical Seed Production and StemEdit Gene Editing ServicesBELTSVILLE, Md., March 3, 2026 /PRNewswire/ -- REPROCELL (TYO: 4978) today announced the launch of its ...

Creative Biolabs launches expanded iPSC and astrocyte differentiation services to support next‑generation disease modeling and neurobiology research.

Bionano Symposium 2026 continues with Day 3: OGM Making its Mark in Constitutional Genetic Disorders on February 25, 2026, from 7:00-10:00 AM PT. Attendees may also explore scientific posters ...

Scientists have identified prematurely aged astrocytes in the brains of Alzheimer’s patients, particularly those with the APOE4 risk gene. Their findings suggest that cellular senescence in these ...

NASA will stream the live undocking of SpaceX Dragon from the International Space Station on Feb. 26, 2026, with research samples returning to Earth.

Select the journal/section where you want your idea to be submitted: Disorders of the central nervous system (CNS), including neurodegenerative, ischemic, neuroinflammatory, and traumatic conditions, ...

Emerging research in cellular reprogramming, gene editing, and regenerative medicine is driving interest in preventive longevity medicine. Some researchers argue aging may be treated as a modifiable ...